IBUPROFEN Heumann painkillers 400 mg, 30 pcs

Instructions for use for IBUPROFEN Heumann painkillers 400 mg, 30 pcs

Detailed instructions for IBUPROFEN Heumann painkillers 400 mg, 30 pcs

Field of use

• The preparation is an anti-inflammatory and pain relieving drug (non-steroidal anti-inflammatory/analgesic).
• Application areas
  • The medicine is used at
    • easy to moderately severe pain such as headache, toothache, regulation pain;
    • Fever.

Active ingredients / ingredients / ingredients

1 Film -coated tablet contains 400 mg ibuprofen. Other components: High-disperse silicon dioxide, microcrystalline cellulose, pre-clerk starch, carboxymethylar stake sodium (Ph.), Talkum, magnesium stearate (Ph.), Hypromellose, Titandioxide (E 171), Lactosemonohydrate, macrogol 4000, sodium citrate.

Contradictions

• The medicine must not be used/applied
  • in the case of known hypersensitivity to the active ingredient ibuprofen or one of the other components of the drug;
  • if you have reacted in the past with asthma attacks, nasal mucus swelling or skin reactions after taking acetylsalicylic acid or other non-steroidal inflammatory inhibitors;
  • in the case of unexplained blood formation disorders;
  • in the event of existing or repeated stomach/duodenum ulcers (peptic ulcers) or bleeding (at least 2 different episodes of proven ulcers or bleeding);
  • in the case of gastrointestinal bleeding or breakthrough (perforation) in the history in connection with previous therapy with non-steroidal anti-rheumatics/anti-inflammatory drugs (NSAID);
  • for brain bleeding (cerebrovascular bleeding) or other active bleeding;
  • in severe liver or kidney dysfunction;
  • with severe heart failure (heart failure);
  • in the last third of the pregnancy;
  • in children under 20 kg (6 years), since this dose strength is usually not suitable due to the active ingredient content.

dosage

• Unless otherwise prescribed by the doctor, the following dosage guidelines apply
  • Always take the preparation exactly according to instructions. Please ask your doctor or pharmacist if you are not quite sure.
  • Do not take it for more than 4 days without medical or dental advice.
  • Unless otherwise prescribed by the doctor, the usual dose is:
    • Body weight (age): 20 kg - 29 kg (6 - 9 years)
      • Single dose in number of tablets: 1/2 film -coated tablet
      • max. Daily dose in the number of tablets: up to 1 1/2 film -coated tablets
    • Body weight (age): 30 kg - 39 kg (10 - 12 years)
      • Single dose in number of tablets: 1/2 film -coated tablet
      • max. Daily dose in the number of tablets: 2 film -coated tablets
    • Body weight (age): > 40 kg (children and adolescents from 12 years and adults)
      • Single dose in number of tablets: 1/2 - 1 film -coated tablet
      • max. Daily dose in the number of tablets: 3 film -coated tablets
  • If you have taken/applied the maximum single dose, wait at least 6 hours until the next intake/application.
  • Dosage in older people:
    • No special dose adjustment is required.
• Please speak to your doctor or pharmacist if you have the impression that the effect of the drug is too strong or too weak.

• WEnn you have taken/applied a larger amount than you should:
  • Use/apply the medicine according to the instructions of the doctor or according to the specified dosage instructions. If you have the feeling that you do not feel sufficient pain relief, then do not increase the dosage independently, but ask your doctor.
  • Central nervous disorders such as headaches, dizziness, dunging and unconsciousness (in children also seizures) as well as abdominal pain, nausea and vomiting can occur as symptoms of overdose. Furthermore, bleeding in the gastrointestinal tract and functional disorders of the liver and kidneys are possible. Furthermore, blood pressure drop, reduced breathing (respiratory depression) and the blue -red color of the skin and mucous membranes (cyanosis) can occur.
  • There is no specific antidote (antidot).
  • If you suspect an overdose, please notify your doctor. According to the severity of poisoning, this can decide on the measures necessary.

• If you have forgotten the intake/application:
  • If you have forgotten the intake/application, take/use the usual recommended quantity.

Taking

• Please take the film -coated tablets unscrewed with plenty of liquid (e.g. a glass of water) during or after a meal.
• For patients who have a sensitive stomach, it is advisable to take the preparation during meals.

Patient information

• Warnings and Precautions
  • Security in the gastrointestinal tract
    • Simultaneous use with other non-steroidal inflammatory inhibitors, including so-called COX-2 inhibitors (cyclooxygenase-2 inhibitors), should be avoided.
    • Side effects can be reduced by using the lowest effective dose via the shortest period required for symptom control.
    • Older patients:
      • In older patients, side effects occur more frequently after using NSAR, in particular bleeding and breakthroughs in the stomach and intestinal area, which may be life-threatening. Therefore, particularly careful medical monitoring is required in older patients.
    • Bleeding of the gastrointestinal tract, ulcers and breakthroughs (perforations):
      • Bleeding of the gastrointestinal tract, ulcers and perforations, also with a fatal outcome, were reported during treatment with all NSAIDs. They occurred with or without prior warning symptoms or serious events in the gastrointestinal tract in the prehistory at any time of therapy.
      • The risk of the occurrence of gastrointestinal bleeding, ulcers and breakthroughs is higher with increasing NSAR dose, in patients with ulcers in the history, especially with the complications bleeding or breakthrough, and in older patients. These patients should begin treatment with the lowest available dose.
      • For these patients as well as for patients who need accompanying therapy with low-dose acetylsalicylic acid (ASA) or other medicines that can increase the risk of gastrointestinal diseases, a combination therapy with gastric mucosa should protect drugs (e.g. misoprostol or Proton pump inhibitors).
      • If you have a history of side effects on the gastrointestinal tract, especially at older age, you should report any unusual symptoms in the abdomen (especially gastrointestinal bleeding), especially at the beginning of therapy.
      • Caution is advisable if you get medicines that can increase the risk of ulcers or bleeding, such as: B. Oral corticosteroids, anti-blood clotting drugs such as warfarin, selective serotonin reuptake inhibitors that are used, among other things, to treat depressive moods, or thrombocyte aggregation inhibitors such as ASA.
      • If you have gastrointestinal bleeding or ulcers during treatment with this preparation, the treatment must be discontinued.
      • Nsar should be in patients with a gastrointestinal Disease in prehistory (ulcerative colitis, Crohn's disease) are used with caution because your condition can deteriorate.
  • Effects on the cardiovascular system
    • Anti -inflammatory agents/painkillers such as ibuprofen can go hand in hand with a slightly increased risk of heart attack or stroke, especially when using in high doses. Do not exceed the recommended dose or duration of treatment.
    • You should discuss your treatment with your doctor or pharmacist before taking the medicine
      • having heart disease, including heart failure (heart failure) and angina pectoris (chest pain), or a heart attack, a bypass surgery, peripheral arterial disease (circulatory disorders in the legs or feet due to narrowed or closed arteries) or any kind of stroke (including mini -Stroke or transitory ischemic attack, "tia").
      • Heavy prints, diabetes or high cholesterol levels or heart diseases or strokes occur in their family history or when they are smokers.
  • Skin reactions
    • Under NSAR therapy, serious skin reactions with redness and bladder formation, some with a fatal outcome, were reported (exfediative dermatitis, Stevens-Johnson syndrome and toxic epidermal necrolysis/lyell syndrome). The highest risk of such reactions seems to exist at the beginning of therapy, since these reactions occurred in the majority of cases in the first month of treatment. At the first sign of rashes, mucosal defects or other signs of a hypersensitivity reaction, the medicine should be discontinued and the doctor should be consulted immediately.
    • An application should be avoided during a chickenpox infection (varicella infection).
  • Other information
    • The medicine should only be used with the strict weighing of the benefit-risk ratio:
      • for certain innate blood formation disorders (e.g. acute intermittent porphyria);
      • for certain autoimmune diseases (systemic lupus erythematosus and mixed collagenosis).
    • A particularly careful medical monitoring is required:
      • with limited kidney or liver function;
      • directly after larger surgical interventions;
      • in allergies (e.g. skin reactions to other medicinal products, asthma, hay fever), chronic nasal mucosal swelling or chronic respiratory diseases narrowing.
    • Severe acute hypersensitivity reactions (e.g. anaphylactic shock) are very rarely observed. At the first sign of a severe hypersensitivity reaction after taking/administration, the therapy must be canceled. The symptoms corresponding, medically required measures must be initiated by expert persons.
    • Ibuprofen, the active ingredient of this preparation, can temporarily inhibit the platelet function (thrombocyte aggregation). Patients with blood clotting disorders should therefore be carefully monitored.
    • When the use of ibuprofen-containing medicinal products at the same time, the anticoagulant effect of low-dose acetylsalicylic acid (prevention of the development of blood clots) can be impaired. In this case, you should therefore not use ibuprofen-containing medicines without the express instruction of your doctor.
    • If you are taking on medicinal products at the same time to inhibit blood clotting or to reduce the blood sugar, the blood clotting or blood sugar levels should take place as a precaution.
    • If Ibuprofen is permanently involved, regular control of the liver values, kidney function and the blood count is required.
    • When taking surgical interventions, the doctor or dentist must be questioned or informed.
    • If painkillers are used for a long time, headaches can occur, which may not be treated by increased doses of the drug. Ask your doctor for advice if you often suffer from headache despite taking this preparation!
    • In general, the habitual intake of painkillers, especially when combined several pain relievingr active ingredients, lead to permanent kidney damage with the risk of kidney failure (analgesic nephropathy).
    • The preparation belongs to a group of medicinal products (non-steroidal anti-rheumatics) that can affect the fertility of women. This effect is reversible after stopping the drug (reversible).
  • Children and adolescents
    • Please note the information in category "contraindications".

• Wateriness and operating machines
  • Since when using the drug in higher dosage, central nervous side effects such as tiredness and dizziness can occur, the reaction capacity can be changed in individual cases and the ability to actively participate in road traffic and to operate machines can be impaired. This applies even more in combination with alcohol. You can then no longer react quickly and specifically to unexpected and sudden events. Do not drive a car or other vehicles in this case! Do not operate any tools or machines! Do not work without a safe grip!

Pregnancy

• Pregnancy
  • If pregnancy is determined during an application of the drug, the doctor must be notified. You can only use ibuprofen in the first and second thirds of pregnancy after consultation with your doctor. In the last third of pregnancy, the preparation must not be used due to an increased risk of complications for mother and child.
• Breastfeeding
  • The active ingredient ibuprofen and its dismantling products only pass into breast milk in small quantities. Since disadvantageous consequences for the infant have not yet become known, breastfeeding will generally not be necessary for short -term use. If a longer use or intake of higher doses is prescribed, however, an early wing should be considered.

Hints